Close

Techno Trends

Biocon Q4 net profit falls 54% to Rs 113 crore

Biotechnology firm Biocon on Friday reported a 54.51 per cent fall in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended March 31, 2014.The company had posted a net profit of Rs 248.61 crore in...

Lupin forms JV with Japan’s Yoshindo Inc

Drug major Lupin has entered into a joint venture pact with Toyama-based Yoshindo Inc to form a new entity which will be responsible for development as well as obtaining marketing access for products in the Japanese market. ...

Xenometrix – Mutagenicity Assays and Cytotoxicity Screening Kits

Xenometrix produces and distributes today's most advanced mutagenicity assays and cytotoxicity screening kits designed to help reduce hands-on time, test compound consumption, plastic waste and consequently the cost. Xenometrix has been developing high quality Ames fluctuation...

Avisoft Bioacoustics – Monitoring Equipment for Mice and Rat Ultrasonic Vocalisations

Avisoft Bioacoustics provides cutting-edge equipment for monitoring mice and rat ultrasonic vocalisations (USV) in drug development procedures and basic research in neuroscience. USV are used as an indicator of the emotional and motivational status in animal models of stress,...

DNA Electronics Secures Funding From Genting Berhad To Develop Genalysis® Point-of-Care Genomic Diagnostics Product Line

DNA Electronics Ltd (DNAe), a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it had successfully secured the necessary funding for DNAe to develop the Genalysis® point-of-care genomic diagnostic product line. The majority of...

Amgen, MGH, Broad Institute to discover new drugs to treat inflammatory bowel disease

Amgen (AMGN), Massachusetts General Hospital (MGH) and the Broad Institute have entered inot a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory bowel disease (IBD). The collaboration...

LabCorp Announces Availability of Newly Approved Viral Load Assay for Hepatitis C Virus

Laboratory Corporation of America® Holdings today announced that it is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test v2.0. With enhanced sensitivity this quantitative viral load assay for Hepatitis C virus (HCV) enables more accurate assessments of response to antiviral...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read